Penumbra Class I Recall Again Raises Concerns About 510(k) Pathway, Device Creep
Executive Summary
A case study of the Penumbra JET 7 class I recall in JAMA has again raised concerns about shortcomings in the US FDA’s 510(k) pathway in the medical community.
You may also be interested in...
US FDA Proposes Independent Contractor To Track User Fee Dollars Used To Pay FTEs
The agency published minutes from three MDUFA V user fee meetings with medtech industry. The talks include conversations about carryover funds and filling FTEs from past user fee deals.
FDA Official: Uptick In PMA, 510(k) Applications Calls For More User Fee Dollars
The number of PMA and 510(k) applications have been steadily growing and becoming harder to review as they’ve become more complex – which an FDA official says means the agency needs more financial resources.
Class I Recall On Penumbra Catheter After Death, Injury Reports
At least 14 stroke patient deaths have been linked to JET 7 catheters with Xtra Flex Technology since they were introduced last year.